Wannag A, Aaseth J
Acta Pharmacol Toxicol (Copenh). 1980 Feb;46(2):81-8. doi: 10.1111/j.1600-0773.1980.tb02425.x.
The distribution and excretion of mercury were studied in mice and rats given a single injection of HgCl2 combined with chelation treatment. BAL-sulph (2,3-dimercaptopropane-1-sulphonate) given intravenously (500 mumol SH/kg) to mice 24 hrs after the mercury injection (2.0 mumol Hg/kg) reduced the kidney Hg-level significantly, while NAPA (N-acetyl-DL-penicillamine) and BAL (2,3-dimercaptopropanol) did not. Severe kidney damage with oliguria was observed in pregnant as well as in non-pregnant rats after injection of 5 mumol/kg of HgCl2. The gross pathological changes could be avoided with immediate treatment with BAL-sulph (500 mumol SH/kg), and such treatment protect against the oliguric reaction. Treatment delayed for 24 hrs reduced the renal Hg-levels significantly, but was ineffective in preventing the kidney damage. This indicates that irreversible changes might have occurred in kidneys cells at this time. The Hg-levels in the brain were either unchanged or lowered in animals given BAL-sulph treatment. BAL-sulph is supposed to act by chelation Hg++, particularly in the extracellular space. The complexes formed appears to be rapidly excreted by healthy kidneys. Mercury poisoning with severe renal damage is, however, associated with a block in urinary Hg-excretion. The poisoned animals responded on the BAL-sulph treatment with a substantial raise of faecal mercury excretion.
研究了单次注射HgCl₂并结合螯合治疗后汞在小鼠和大鼠体内的分布与排泄情况。汞注射(2.0 μmol Hg/kg)24小时后给小鼠静脉注射BAL-磺酸盐(2,3-二巯基丙烷-1-磺酸盐,500 μmol SH/kg)可显著降低肾脏汞含量,而N-乙酰-DL-青霉胺(NAPA)和2,3-二巯基丙醇(BAL)则无此效果。给怀孕和未怀孕的大鼠注射5 μmol/kg HgCl₂后,观察到严重的肾损伤并伴有少尿。立即用BAL-磺酸盐(500 μmol SH/kg)治疗可避免大体病理变化,且这种治疗可预防少尿反应。延迟24小时治疗可显著降低肾脏汞含量,但对预防肾损伤无效。这表明此时肾细胞可能已发生不可逆变化。接受BAL-磺酸盐治疗的动物大脑中的汞含量要么未变,要么降低。BAL-磺酸盐被认为通过螯合Hg²⁺起作用,尤其是在细胞外空间。形成的复合物似乎能被健康的肾脏迅速排泄。然而,伴有严重肾损伤的汞中毒与尿汞排泄受阻有关。中毒动物对BAL-磺酸盐治疗的反应是粪便汞排泄大幅增加。